XRN Q3 2026 Same-Property Cash NOI Growth (Outpatient Medical) +1.6%, Beat Guidance by +0.1 pts

Same-Property Cash NOI growth (Outpatient Medical) of +1.6% in Q3 2026 was in line with the FY 2026 guidance range of 1.0% to 2.0% (midpoint 1.5%).

Net loss widened to $8.9 million ($0.67 per share) from $6.0 million ($0.45 per share) in the prior year period.

FFO per share declined 50% to $0.50 from $1.00, and Core FFO per share fell 33% to $0.75 from $1.12.

Total revenue increased 8.3% year-over-year to $40.3 million, driven by $6.2 million in resident fees and services from the newly acquired SHOP portfolio.

G&A expenses of $7.7 million included $2.0 million in severance and transition expenses related to the strategic pivot to Seniors Housing.

The company completed the acquisition of The Pinnacle, a 175-home seniors housing community in North Bethesda, Maryland, for $173.2 million in October 2026.

The company is actively pursuing the disposition of its outpatient medical portfolio and has engaged a broker to facilitate the process.